Ranbaxy, Takeda Strike Licensing Deal Over Actos
Ranbaxy Laboratories Ltd. has agreed to license Takeda Pharmaceutical Co. Ltd.'s Actos patents in order to end a protracted legal battle and bring a generic version of the blockbuster diabetes treatment...To view the full article, register now.
Already a subscriber? Click here to view full article